Cargando…

New roles for Fc receptors in neurodegeneration-the impact on Immunotherapy for Alzheimer's Disease

There are an estimated 18 million Alzheimer's disease (AD) sufferers worldwide and with no disease modifying treatment currently available, development of new therapies represents an enormous unmet clinical need. AD is characterized by episodic memory loss followed by severe cognitive decline a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fuller, James P., Stavenhagen, Jeffrey B., Teeling, Jessica L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139653/ https://www.ncbi.nlm.nih.gov/pubmed/25191216 http://dx.doi.org/10.3389/fnins.2014.00235

Ejemplares similares

Turning On Lights to Stop Neurodegeneration: The Potential of Near Infrared Light Therapy in Alzheimer's and Parkinson's Disease
por: Johnstone, Daniel M., et al.
Publicado: (2016)

Comparing the efficacy and neuroinflammatory potential of three anti-abeta antibodies
por: Fuller, James P., et al.
Publicado: (2015)

Antibody Engineering for Optimized Immunotherapy in Alzheimer's Disease
por: Sumner, Isabelle L., et al.
Publicado: (2018)

Challenges in Neurodegeneration Research
por: Noble, Wendy, et al.
Publicado: (2010)

Parkinson's Disease and Neurodegeneration: GABA-Collapse Hypothesis
por: Błaszczyk, Janusz W.
Publicado: (2016)

Neurodegeneration Behind Bars: from Molecules to Jurisprudence
por: Sfera, Adonis, et al.
Publicado: (2014)

Loss of tau rescues inflammation-mediated neurodegeneration
por: Maphis, Nicole, et al.
Publicado: (2015)

Editorial: Unraveling Neuroprotective and Neurodegenerative Signals in Neurodegeneration
por: Vega, Irving E., et al.
Publicado: (2016)

Intracerebral immune complex formation induces inflammation in the brain that depends on Fc receptor interaction
por: Teeling, Jessica L., et al.
Publicado: (2012)

Role of membrane biophysics in Alzheimer's–related cell pathways
por: Zhu, Donghui, et al.
Publicado: (2015)

Alteration of Golgi Structure by Stress: A Link to Neurodegeneration?
por: Alvarez-Miranda, Eduardo A., et al.
Publicado: (2015)

CB(2) Cannabinoid Receptor As Potential Target against Alzheimer's Disease
por: Aso, Ester, et al.
Publicado: (2016)

Cannabinoid Type 2 (CB(2)) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson's Disease
por: Javed, Hayate, et al.
Publicado: (2016)

The Impact of the COVID-19 Pandemic on Alzheimer's Disease and Other Dementias
por: Gan, Jinghuan, et al.
Publicado: (2021)

Alpha-synuclein Toxicity in the Early Secretory Pathway: How It Drives Neurodegeneration in Parkinsons Disease
por: Wang, Ting, et al.
Publicado: (2015)

NK Cell-Fc Receptors Advance Tumor Immunotherapy
por: Sanseviero, Emilio
Publicado: (2019)

A-Subclass ATP-Binding Cassette Proteins in Brain Lipid Homeostasis and Neurodegeneration
por: Piehler, Armin P., et al.
Publicado: (2012)

Antibody-mediated clearance of tau in primary mouse microglial cultures requires Fcγ-receptor binding and functional lysosomes
por: Andersson, Christian Rungsted, et al.
Publicado: (2019)

Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration
por: Ryu, Jae Kyu, et al.
Publicado: (2018)

Editorial: Alzheimer's Disease From a Psychiatric Perspective: Towards New Therapeutic Guidelines?
por: Fakhoury, Marc, et al.
Publicado: (2021)

Immune complex formation impairs the elimination of solutes from the brain: implications for immunotherapy in Alzheimer’s disease
por: Carare, Roxana Octavia, et al.
Publicado: (2013)

Fc γ receptor compositional heterogeneity: Considerations for immunotherapy development
por: Barb, Adam W.
Publicado: (2020)

Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration
por: Perry, V. Hugh, et al.
Publicado: (2013)

Alzheimer's Disease: Challenges Ahead
por: Sigurdsson, Einar M.
Publicado: (2010)

Noradrenergic dysfunction in Alzheimer's disease
por: Gannon, Mary, et al.
Publicado: (2015)

Golgi fragmentation in Alzheimer's disease
por: Joshi, Gunjan, et al.
Publicado: (2015)

Brain Stimulation in Alzheimer's Disease
por: Chang, Chun-Hung, et al.
Publicado: (2018)

Molecular Bases of Alzheimer’s Disease and Neurodegeneration: The Role of Neuroglia
por: Luca, Antonina, et al.
Publicado: (2018)

Attempted and Successful Compensation in Preclinical and Early Manifest Neurodegeneration – A Review of Task fMRI Studies
por: Scheller, Elisa, et al.
Publicado: (2014)

Neurological Soft Signs in Aging, Mild Cognitive Impairment, and Alzheimer’s Disease – The Impact of Cognitive Decline and Cognitive Reserve
por: Urbanowitsch, Nadja, et al.
Publicado: (2015)

ABC Transporters and the Alzheimer’s Disease Enigma
por: Wolf, Andrea, et al.
Publicado: (2012)

Nutrition, Gut Microbiota, and Alzheimer's Disease
por: Romanenko, Mariana, et al.
Publicado: (2021)

Altered gray matter volume and functional connectivity in medial orbitofrontal cortex of bulimia nervosa patients: A combined VBM and FC study
por: Li, Wei-hua, et al.
Publicado: (2022)

Editorial: Roles of Fc Receptors in Disease and Therapy
por: Ganesan, Latha P., et al.
Publicado: (2020)

Kynurenines, neurodegeneration and Alzheimer’s disease
por: Kincses, Zsigmond Tamas, et al.
Publicado: (2010)

Protective effect of irisin against Alzheimer’s disease
por: Chen, Kang, et al.
Publicado: (2022)

Accuracy of Raman spectroscopy in the diagnosis of Alzheimer's disease
por: Xu, Yanmei, et al.
Publicado: (2023)

The Role of Microglia in Retinal Neurodegeneration: Alzheimer's Disease, Parkinson, and Glaucoma
por: Ramirez, Ana I., et al.
Publicado: (2017)

The Role of Mitochondrial Impairment in Alzheimer´s Disease Neurodegeneration: The Tau Connection
por: Quntanilla, Rodrigo A., et al.
Publicado: (2020)

Immunotherapy in Autoantibody-Associated Psychiatric Syndromes in Adults
por: Hansen, Niels, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i929nrcang52bhijeai32al7j4